LACOG – The Latin American Cooperative Oncology Group – is a non-profit organization, founded in 2009 by a group of Latin-American oncologist doctors, interested in developing clinical research. This is the first multinational cooperative group in Latin America, exclusively dedicated to clinical and translational cancer research. LACOG currently counts on more than 542 investigators members, present in 259 institutions from 16 Latin America countries.

The group develops observational studies to assess diagnosis, treatment and survival of cancer patients in Latin America, in several types of tumors, and also develops clinical trials with new drugs in such countries. The main purpose is to assess the Latin American population and how treatment impacts the lives of such patients, as well as develop innovative trials with new drugs, also in partnership with other collaborative groups world widely.

LACOG has also the goal of constructing a network of oncology investigators in Latin America, in order to develop, conduct and coordinate academic studies and clinical researches in the region. LACOG also seeks cooperation with other international academic institutions, biotechnological/pharmaceutical networks and industries, promoting and conducting clinical researches